Search research articles
Contact Us
Filters
Showing results (321-330 of 372) with videos related to
Page
of 38
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 13, 2017
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
Amr Alaarg, Max L Senders, Aida Varela-Moreira, et al.
Macromolecular Bioscience
|
October 15, 2011
Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue
M E Emmy M Dolman, Kim M A van Dorenmalen, Ebel H E Pieters, et al.
The Prostate
|
February 10, 2015
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo
Jan Kroon, Jeroen T Buijs, Geertje van der Horst, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 10, 2012
Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment
Roy van der Meel, Sabrina Oliveira, Isil Altintas, et al.
The Journal of Investigative Dermatology
|
April 18, 2015
In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses
Cynthia M Fehres, Astrid J van Beelen, Sven C M Bruijns, et al.
Journal of Materials Chemistry. B
|
November 2, 2013
In Vivo Nanotoxicity Testing using the Zebrafish Embryo Assay
Larissa Y Rizzo, Susanne K Golombek, Marianne E Mertens, et al.
Journal of Leukocyte Biology
|
October 12, 2007
Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134
Esther N M Nolte-'t Hoen, Elmieke P J Boot, Josée P A Wagenaar-Hilbers, et al.
Pharmaceutics
|
May 25, 2024
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells
Aram M de Haas, Dorian A Stolk, Sjoerd T T Schetters, et al.
ACS Nano
|
April 2, 2015
Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles
Yang Shi, Roy van der Meel, Benjamin Theek, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 18, 2022
Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management
Jacinta O Pinho, Mariana Matias, Vanda Marques, et al.
Page
of 38
Search research articles
Search
Showing results (321-330 of 372) with videos related to
Sort By:
Page
of 38
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 13, 2017
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
Amr Alaarg, Max L Senders, Aida Varela-Moreira, et al.
Macromolecular Bioscience
|
October 15, 2011
Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue
M E Emmy M Dolman, Kim M A van Dorenmalen, Ebel H E Pieters, et al.
The Prostate
|
February 10, 2015
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo
Jan Kroon, Jeroen T Buijs, Geertje van der Horst, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 10, 2012
Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment
Roy van der Meel, Sabrina Oliveira, Isil Altintas, et al.
The Journal of Investigative Dermatology
|
April 18, 2015
In situ Delivery of Antigen to DC-SIGN(+)CD14(+) Dermal Dendritic Cells Results in Enhanced CD8(+) T-Cell Responses
Cynthia M Fehres, Astrid J van Beelen, Sven C M Bruijns, et al.
Journal of Materials Chemistry. B
|
November 2, 2013
In Vivo Nanotoxicity Testing using the Zebrafish Embryo Assay
Larissa Y Rizzo, Susanne K Golombek, Marianne E Mertens, et al.
Journal of Leukocyte Biology
|
October 12, 2007
Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134
Esther N M Nolte-'t Hoen, Elmieke P J Boot, Josée P A Wagenaar-Hilbers, et al.
Pharmaceutics
|
May 25, 2024
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells
Aram M de Haas, Dorian A Stolk, Sjoerd T T Schetters, et al.
ACS Nano
|
April 2, 2015
Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles
Yang Shi, Roy van der Meel, Benjamin Theek, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 18, 2022
Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management
Jacinta O Pinho, Mariana Matias, Vanda Marques, et al.
Page
of 38